Piccinno, Gianmarco https://orcid.org/0000-0003-1947-1817
Thompson, Kelsey N. https://orcid.org/0000-0002-9074-9116
Manghi, Paolo https://orcid.org/0000-0003-0846-6529
Ghazi, Andrew R.
Thomas, Andrew Maltez https://orcid.org/0000-0001-5789-3354
Blanco-Míguez, Aitor https://orcid.org/0000-0001-7386-5572
Asnicar, Francesco https://orcid.org/0000-0003-3732-1468
Mladenovic, Katarina https://orcid.org/0009-0002-6181-0296
Pinto, Federica https://orcid.org/0000-0002-4539-4811
Armanini, Federica
Punčochář, Michal https://orcid.org/0000-0002-1915-9391
Piperni, Elisa https://orcid.org/0000-0001-9361-7875
Heidrich, Vitor https://orcid.org/0000-0001-6617-9187
Fackelmann, Gloria
Ferrero, Giulio https://orcid.org/0000-0002-4580-0680
Tarallo, Sonia
Nguyen, Long H. https://orcid.org/0000-0002-5436-4219
Yan, Yan
Keles, Nazim A.
Tuna, Bilge G.
Vymetalkova, Veronika
Trompetto, Mario
Liska, Vaclav
Hucl, Tomas
Vodicka, Pavel
Bencsiková, Beatrix
Čarnogurská, Martina
Popovici, Vlad
Marmorino, Federica
Cremolini, Chiara
Pardini, Barbara https://orcid.org/0000-0001-9571-4257
Cordero, Francesca https://orcid.org/0000-0002-3143-3330
Song, Mingyang
Chan, Andrew T. https://orcid.org/0000-0001-7284-6767
Derosa, Lisa
Zitvogel, Laurence https://orcid.org/0000-0003-1596-0998
Huttenhower, Curtis https://orcid.org/0000-0002-1110-0096
Naccarati, Alessio https://orcid.org/0000-0001-5774-0905
Budinska, Eva
Segata, Nicola https://orcid.org/0000-0002-1583-5794
Article History
Received: 10 April 2024
Accepted: 2 April 2025
First Online: 3 June 2025
Competing interests
: N.S. is a founder and shareholder of PreBiomics Srl and is on the scientific advisory board of ZOE Ltd and received consultancy fees from them. C.H. is a member of the Seres Therapeutics and Empress Therapeutics scientific advisory boards. L.Z. is a founder of Biotech. Cie everImmune involved in the cancer/microbiome space, the president of everImmune scientific advisory board (SAB) and received honoraria from everImmune. L.Z. received research contract fundings from Daiichi Sankyo and Biomérieux. The other authors declare no competing interests.